Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 4Terminated 2Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 299Thoracic 59Gynecologic 51Gastrointestinal 48Head & Neck 43Genitourinary 32Dermatologic 24Sarcoma 11Other solid neoplasm 5Lymphoid 5CNS 4Other hematologic neoplasm 1NET 1Endocrine 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 541Precursor Cell Lymphoblastic Leukemia-Lymphoma 310Hematologic Neoplasms 264Leukemia 179Myelodysplastic Syndromes 170Leukemia, Lymphocytic, Chronic, B-Cell 168Lymphoma 101Lymphoma, Non-Hodgkin 94Recurrence 84Neoplasms 83Multiple Myeloma 82Leukemia, Myelogenous, Chronic, BCR-ABL Positive 72Leukemia, Myelomonocytic, Chronic 61Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 58Burkitt Lymphoma 54Leukemia, Biphenotypic, Acute 48Myeloproliferative Disorders 45Lymphoma, Follicular 43Lymphoma, Mantle-Cell 42Lymphoma, Large B-Cell, Diffuse 42Hodgkin Disease 34Lymphoma, B-Cell 32Lymphoma, B-Cell, Marginal Zone 30Leukemia, B-Cell 30Anemia, Refractory, with Excess of Blasts 30Primary Myelofibrosis 28Leukemia, Plasma Cell 23Waldenstrom Macroglobulinemia 22Neoplasm, Residual 21Leukemia, Myeloid, Chronic-Phase 21

Interventions

tislelizumab 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Triple Negative Breast Neoplasms × Other hematologic neoplasm × Clear all
NCT05768932 2026-03-27

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

SillaJen, Inc.

Phase 1 Recruiting
260 enrolled
BreastGastrointestinalOther hematologic neoplasm

Carcinoma, Stomach Neoplasms, Leukemia, Myeloid, Acute, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡